The working agenda for LSPN Asia is below. It will continue to be updated over the coming weeks so please check back regulary for updates. 
If you would like to view the agenda for LSPN Boston please click here
Time Name Description
Thursday, October 12, 2017
8:00 AM - 8:30 AMREGISTRATION 
9:00 AM - 9:10 AMCHAIRMAN'S OPENING ADDRESS
Peter Scott
Group Publisher
Life Sciences IP Review
9:10 AM - 9:40 AMGLOBAL INSIGHT

Global Patent Protection: Market Status and Outlook
 

David Albagli, Local Partner Tokyo, White & Case

9:40 AM - 10:10 AMSINGAPORE FOCUS

Singapore’s IP Hub Master Plan:

·         Strategies in building awareness and competency in IP
·         Ensuring the protection of intellectual capital
·         How will the protection of intellectual capital benefit Singapore’s economy?
 
 
Tan Shau En
Executive Director
IP ValueLab (a subsidiary of IPOS)
10:10 AM - 10:40 AMEUROPE FOCUS

 

Biotech Patentability Issues in Europe
  • Plausibility at the EPO – what is it and what should you do about it
  • Parallels with other jurisdictions
  • Plausibility in the UK courts
  • Rule changes at the EPO
 
 
Iain Armstrong 
Partner
HGF
10:40 AM - 11:15 AMMORNING COFFEE AND NETWORKING IN THE EXHIBITION HALL 
11:15 AM - 11:30 AMSPOTLIGHT ON JAPAN
Key Supreme Court and High Court Grand Panel Decisions in Japan
 
Shinjiro Ono      
Managing Partner, Head of Patent Division        
Yuasa and Hara
11:30 AM - 12:00 PMCRISPR FOCUS
CRISPR: What’s the Licensing Outlook and Where are the Opportunities?
 
Steve Maebius 
Partner
Foley & Lardner
12:00 PM - 12:30 PMIN-HOUSE COUNSEL PANEL DISCUSSION

In-house Counsel Share Legal Challenges: Securing and Protecting Patents

  • What are the day-to-day challenges for in-house counsel in securing IP rights?
  • What do we need from private practice attorneys?
  • Infringement: What should be our strategy in Patent Enforcement? 
Moderator:
Sunita Sreedharan
Founder & CEO
SKS Law Associates
 
Panellists:
Tony Liang         
Senior IP Counsel           
Bayer
 
Cheryl Pang
Patent Counsel
Procter & Gamble
 
Liling Heng        
Patent Counsel-Innovation - Asia Legal, Homecare         
Procter & Gamble
12:30 PM - 1:00 PMLICENSING
Turning Your Patents Into Money: Structuring Licences: Key Issues to Watch out for and Practical Tips
 
Ben Goodger    
General Counsel    
Aslan Pharmaceuticals
1:00 PM - 1:45 PMLUNCH AND NETWORKING IN THE EXHIBITION HALL

 

1:45 PM - 2:00 PMROUNDTABLE DISCUSSIONS
Taking part in these discussions offers delegates and speakers the opportunity to focus on topics of specific interest, within a small group. 45 minutes is set aside for each rotation – and delegates may choose two discussion tables. The roundtable discussion groups give delegates even more opportunity to share knowledge and opinion, and ends with a moderator round-up of key findings, providing delegates with an insight into all eight topics.
 
SESSION 1 - PLEASE CHOOSE YOUR FIRST TABLE FROM THE FOLLOWING:
2:05 PM - 2:45 PMTABLE TWO
Strategies in Second Medical Use Cases
Shinjiro Ono
Managing Partner, Head of Patent Division
Yuasa & Hara
& 
Osamu Yamamoto
Partner 
Yuasa & Hara
2:05 PM - 2:45 PMTABLE FOUR
Licensing Considerations
Ben Goodger
General Counsel
Aslan Pharmaceuticals
2:05 PM - 2:45 PMTABLE SIX
Biotech Patentability Issues in Europe
Iain Armstrong
Partner
HGF
2:05 PM - 2:45 PMTABLE THREE
Securing Patents: Where do I Start?
Alfred Yip
Director of Patents
Intellectual Property Office of Singapore
2:05 PM - 2:45 PMTABLE ONE
Navigating the CRISPR Patent and Licensing Landscape
Steve Maebius
Partner
Foley & Lardner
2:05 PM - 2:45 PMTABLE FIVE
Best Practice in Portfolio Management
Saumya Bareja
General Counsel
Procter & Gamble
2:45 PM - 2:50 PMSESSION 2 - PLEASE CHOOSE YOUR SECOND TABLE FROM THE FOLLOWING:  
2:50 PM - 3:30 PMTABLE TWO
Strategies in Second Medical Use Cases
Shinjiro Ono
Managing Partner, Head of Patent Division
Yuasa & Hara
& 
Osamu Yamamoto
Partner
Yuasa & Hara
2:50 PM - 3:30 PMTABLE ONE
Navigating the CRISPR Patent and Licensing Landscape 
Steve Maebius
Partner 
Foley & Lardner
2:50 PM - 3:30 PMTABLE FOUR
Licensing Considerations
Ben Goodger
General Counsel 
Aslan Pharmaceuticals
2:50 PM - 3:30 PMTABLE SIX
Biotech Patentability Issues in Europe
Iain Armstrong
Partner
HGF
2:50 PM - 3:30 PMTABLE THREE
Securing Patents: Where do I Start?
Alfred Yip
Director of Patents
Intellectual Property Office of Singapore
2:50 PM - 3:30 PMTABLE FIVE
Best Practice in IP Portfolio Management
Saumya Bareja
General Counsel 
Procter & Gamble 
3:30 PM - 3:45 PMROUNDTABLE ROUND UP
Key findings and points of note
3:45 PM - 4:15 PMAFTERNOON TEA AND NETWORKING IN THE EXHIBTION HALL 
4:15 PM - 4:45 PMIP PORTFOLIO MANAGEMENT
Best Practice in IP Portfolio Management
  • Best practice in operating an effective patent portfolio
  • Internal business alignment: Matching commercial expectations with your current patent status
  • Licensing considerations and opportunities
  • How to accurately measure ROI and demonstrate value using IP portfolio metrics
 
Saumya Bareja 
General Counsel             
Procter & Gamble Asia 
4:45 PM - 5:15 PMIN-HOUSE COUNSEL PANEL DISCUSSION
In-house Counsel Share Commercial Challenges: Route-to-Market
  • From Conception to Sale: What are the Considerations in Harnessing your IP?
  • Licensing considerations
  • How can Private Practice Attorneys Help?
 
Moderator:
David Albagli    
Local Partner, Tokyo      
White & Case
 
Panellists:
Tony Liang         
Senior IP Counsel           
Bayer
 
Cheryl Pang
Patent Counsel
Procter & Gamble
 
Liling Heng        
Patent Counsel-Innovation - Asia Legal, Homecare         
Procter & Gamble
5:15 PM - 6:00 PMCHAIRMAN'S CLOSING REMARKS AND DRINKS RECEPTION